Related Articles
CD155 and CD112 as possible therapeutic targets of <em>FLT3</em> inhibitors for acute myeloid leukemia
Expression of the immune checkpoint receptor TIGIT in seminoma
Survival analysis with regard to PD‑L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma
CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis